Screener
Mesa Laboratories MLAB CapEx
CapEx at other companies
Other financials
Where this comes from
Reported directly by Mesa Laboratories in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-026808
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 |
|---|---|---|
| Unearned revenue | (171) | 55 |
| Net cash provided by operating activities | 14,736 | 1,893 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (559) | (1,009) |
| Net cash (used in) investing activities | (559) | (1,009) |
| Cash flows from financing activities: | ||
| Proceeds from debt borrowings | 10,000 | 10,500 |
| Debt repayments | (18,656) | (7,438) |
Document
FAQ
- What is Mesa Laboratories's capex?
- Mesa Laboratories (MLAB) reported capex of $559K in Q2 2026.
- How has Mesa Laboratories's capex changed year-over-year?
- Mesa Laboratories's capex decreased by 44.6% year-over-year, from $1.01M to $559K.
- What is the long-term trend for Mesa Laboratories's capex?
- Over 4 years (2022 to 2026), Mesa Laboratories's capex has grown at a -7.5% compound annual growth rate (CAGR), from $4.43M to $3.25M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Mesa Laboratories's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude